SOLENO THERAPEUTICS INC
SLNO
11 insider filings · Latest: Mar 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Apr 1 12:17 AM | Meredith ManningChief Commercial Officer | Sale | 7,522 | $30.44 | $229.0K | 64,507(D) | View → |
| Mar 27, 2026 | Apr 1 12:15 AM | Michael F. HuangSr. VP of Clinical Development | Sale | 6,582 | $30.44 | $200.4K | 39,823(D) | View → |
| Aug 11, 2025 | Aug 16 1:00 AM | Abingworth Bioventures VII LP | Proposed Sale | 1,347,522 | $82.15 | $110.7M | — | View → |
| Jul 1, 2025 | Jul 1 8:03 PM | PATRICIA HIRANO | Proposed Sale | 3,830 | $82.76 | $317.0K | — | View → |
| Jun 24, 2025 | Jun 24 8:07 PM | PATRICIA HIRANO | Proposed Sale | 266 | $84.25 | $22.4K | — | View → |
| Apr 1, 2025 | Apr 1 8:16 PM | PATRICIA HIRANO | Proposed Sale | 3,782 | $70.11 | $265.2K | — | View → |
| Mar 28, 2025 | Mar 28 8:09 PM | PATRICIA HIRANO | Proposed Sale | 27,662 | $69.40 | $1.9M | — | View → |
| Mar 28, 2025 | Mar 28 4:45 PM | Matthew Pauls | Proposed Sale | 5,937 | $67.39 | $400.1K | — | View → |
| Mar 27, 2025 | Mar 27 8:15 PM | PATRICIA HIRANO | Proposed Sale | 111,124 | $68.31 | $7.6M | — | View → |
| Mar 27, 2025 | Mar 27 12:57 PM | Kristen Yen | Proposed Sale | 97,006 | $50.05 | $4.9M | — | View → |
| Mar 27, 2025 | Mar 27 12:56 PM | Meredith Manning | Proposed Sale | 48,000 | $50.05 | $2.4M | — | View → |
| Mar 27, 2025 | Mar 27 12:55 PM | James H Mackaness | Proposed Sale | 92,500 | $50.05 | $4.6M | — | View → |
| Mar 27, 2025 | Mar 27 12:55 PM | Michael F. Huang | Proposed Sale | 29,625 | $50.05 | $1.5M | — | View → |
| Mar 27, 2025 | Mar 27 12:54 PM | Patricia C Hirano | Proposed Sale | 23,375 | $50.05 | $1.2M | — | View → |
| Mar 27, 2025 | Mar 27 12:53 PM | Bhatnagar Anish | Proposed Sale | 746,041 | $50.05 | $37.3M | — | View → |
| Oct 21, 2024 | Oct 21 8:30 PM | Abingworth Bioventures VII LP | Proposed Sale | 949,336 | $54.16 | $51.4M | — | View → |
| Oct 7, 2024 | Oct 7 8:30 PM | Abingworth Bioventures VII LP | Proposed Sale | 2,522,751 | $49.63 | $125.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 10:59 PM | Jennifer FulkCHIEF FINANCIAL OFFICER | Option Exercise | 67,660 | $39.06 | 67,660(D) | View → |
| Jan 21, 2026 | Jan 23 11:08 PM | Kristen YenOfficer title: SVP Global Clinical Operations and Patient Advocacy | Grant/Award | 11,900 | $43.65 | 11,900(D) | View → |
| Jan 21, 2026 | Jan 23 11:07 PM | Kevin NorrettChief Business Officer | Grant/Award | 4,000 | $43.65 | 4,000(D) | View → |
| Jan 21, 2026 | Jan 23 11:06 PM | Meredith ManningChief Commercial Officer | Grant/Award | 32,800 | $43.65 | 32,800(D) | View → |
| Jan 21, 2026 | Jan 23 11:05 PM | James H MackanessCHIEF FINANCIAL OFFICER | Grant/Award | 32,800 | $43.65 | 32,800(D) | View → |
| Jan 21, 2026 | Jan 23 11:04 PM | Manher JoshiChief Development Officer | Grant/Award | 4,700 | $43.65 | 4,700(D) | View → |
| Jan 21, 2026 | Jan 23 11:02 PM | Michael F. HuangSr. VP of Clinical Development | Grant/Award | 11,900 | $43.65 | 11,900(D) | View → |
| Jan 21, 2026 | Jan 23 11:01 PM | Patricia C HiranoOfficer title: Senior Vice President, Regulatory Affairs | Grant/Award | 11,900 | $43.65 | 11,900(D) | View → |
| Jan 21, 2026 | Jan 23 11:00 PM | Bhatnagar AnishDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 131,400 | $43.65 | 131,400(D) | View → |